Antiphospholipid Antibody Titers and Clinical Outcomes in Patients with Recurrent Miscarriage and Antiphospholipid Antibody Syndrome: A Prospective Study

BACKGROUND: The management of patients with recurrent miscarriage (RM) and antiphospholipid antibody syndrome (APS) includes prolonged treatment with heparin and aspirin, starting from the confirmation of pregnancy and continuing until 6 weeks after birth. This study was conducted to determine the r...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Yu, Wang, Hai-Yan, Qiao, Jie, Liu, Ping, Chi, Hong-Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308007/
https://www.ncbi.nlm.nih.gov/pubmed/28139508
http://dx.doi.org/10.4103/0366-6999.198934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308007/
https://www.ncbi.nlm.nih.gov/pubmed/28139508
http://dx.doi.org/10.4103/0366-6999.198934

Ejemplares similares